MedPath

Stroke complicAtions After TraUmatic expeRieNces and Stress

Completed
Conditions
Stroke
Registration Number
NCT03496480
Lead Sponsor
Johanna Schöner
Brief Summary

The primary aim of this retrospective cohort study is to test the hypothesis that previous traumatization (long) before an ischemic stroke increases the degree of stroke-induced PTSD symptoms at 9-13 months after the stroke event. Secondary outcome parameters include quality of life and depression.

Detailed Description

Neuropsychiatric consequences of brain ischemia play a critical role in shaping long-term stroke outcome. Unfortunately, however, as of now, clinical research and clinical practice have not adequately addressed this growing challenge. A good case in point is posttraumatic stress disorder (PTSD). Previous trauma exposure and posttraumatic stress symptoms may increase the risk of cardiovascular events (Sumner et al., 2015). Moreover, unbeknownst to most clinical neurologists, a significant portion (approximately 25%) of their stroke patients develop symptoms of post-traumatic stress disorder (PTSD) within the first year post-event. PTSD-related symptoms after an acute coronary syndrome increase the risk of recurrent cardiac events and mortality (Edmondson et al., 2012). Similarly, stroke-induced PTSD has been linked with worse long term stroke outcome, in particular, recurrent stroke, greater disability, non-adherence to medications, and comorbidities (Goldfinger et al., 2014; Kronish et al., 2012).

For a period of 22 months, all stroke patients treated at the Charité Medical Center will be screened retrospectively 9-13 months after a first-ever ischemic stroke (\~2000). All eligible patients will be contacted by mail 9-13 months after their hospital stay with the request that they complete the questionnaires. The mailing will also include an information statement, the consent form, as well as a stamped return envelope.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
636
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stroke-induced PTSD9-13 months after stroke

Stroke-induced PTSD will be measured using the Impact of Event Scale - Revised (IES-R).

Secondary Outcome Measures
NameTimeMethod
Trauma exposure9-13 months after stroke

Prior trauma exposure before the infarct is ascertained with the 10-item Brief Trauma Questionnaire (BTQ).

Lifetime PTSD9-13 months after stroke

The occurrence of PTSD symptoms in the study subjects' lifetimes is assessed using the 7-item Short Screening Scale for DSM IV PTSD.

Functional outcome9-13 months after stroke

Functional outcome is measured with the SF-36

Trial Locations

Locations (1)

Charité Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

Charité Universitätsmedizin Berlin
🇩🇪Berlin, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.